Filing Details

Accession Number:
0001235802-11-000022
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-14 10:20:03
Reporting Period:
2011-01-13
Filing Date:
2011-01-14
Accepted Time:
2011-01-14 10:20:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1023024 Biosante Pharmaceuticals Inc BPAX Biological Products, (No Disgnostic Substances) (2836) 582301143
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193522 W Louis Sullivan C/O Biosante Pharmaceuticals, Inc.
111 Barclay Boulevard
Lincolnshire IL 60069
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-13 10,000 $1.72 37,898 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct